HOME >> BIOLOGY >> NEWS
Translational repression in germline development

January 13, 2003 - In many species, the reproductive cells of the germline can only form properly if certain mRNAs are prevented from translating into proteins until they have been transported to precise target locations in the egg and the appropriate developmental stage has been reached. In a study published in the January issue of Developmental Cell, members of the RIKEN Center for Developmental Biology (CDB) Laboratory for Germline Development (Akira Nakamura, Team Leader) report that, in the fruit fly Drosophila, this translational repression is achieved by a newly identified complex formed by three associating proteins.

RNA activity during Drosophila oogenesis involves a number of sequential processes. The Drosophila oocyte share cytoplasm with neighboring nurse cells via an incomplete cell membrane, allowing mRNAs and proteins from the nurse cells to be transported to the oocyte in the form of ribonucleoproteins. Following their export from the nurse cell nuclei, mRNAs are translationally repressed, or masked, and transported to specified regions of the oocyte, where they establish fixed and precise localizations and regain their ability to undergo translation. In one example of this critically important regulation, the translation of the RNA for the maternal gene oskar, which has critical functions in embryonic patterning and the formation of germline cells, is repressed during its transport to the posterior pole of the oocyte. This transcript-specific repression is known to be mediated by the protein Bruno, which binds to the 3' UTR of oskar mRNA, but the underlying mechanisms have remained obscure.

In the Developmental Cell study, the Nakamura lab demonstrated that an ovarian protein, Cup, is another protein required to inhibit the premature translation of oskar mRNA, and that Cup achieves this by binding to a second protein, eIF4E, a 5' cap-binding general translation initiation factor. The binding with Cup prevents eIF4E
'"/>

Contact: Doug Sipp
sipp@cdb.riken.jp
81-78-306-3043
RIKEN Center for Developmental Biology
12-Jan-2004


Page: 1 2

Related biology news :

1. APS Inflammatory Bowel Diseases Translational Research Conference, Sept. 8-11
2. AACR and The V Foundation form Translational Cancer Research Alliance
3. University Of California-San Francisco (UCSF) Translational Symposium, September 10, To Focus On HIV Breakthrough And Immune Function
4. Researchers achieve germline transmission of gene knockdown in mice
5. Bronfenbrenner book sums up human development
6. OutFoxed! New research may redefine late-stage cardiac development
7. Disease diagnosis, drug development focus of UH profs biochip research
8. Jefferson Lab detector technology aids development of cystic fibrosis therapy
9. Joslin Diabetes Center launches research section on developmental and stem cell biology
10. LBP-1a gene mutation linked to disruption of normal fetal development
11. Method to visualize gene activity may provide insight into normal development & genome function

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... ... Brilliant , the leading smart home control and lighting company, today ... purchase in the U.S., Canada, and Puerto Rico through ADI Global Distribution, a leading ... being available for purchase through ADI’s Digital Branch , Brilliant products are now ...
(Date:9/3/2020)... ... 03, 2020 , ... Litmus Health , the research-ready ... of the company’s security practices has been completed. The assessment deemed Litmus infrastructure ... evaluation reviewed Litmus’ processes and systems, assessing them to see whether they adhere ...
(Date:8/26/2020)... ... August 24, 2020 , ... Elgia Therapeutics , a ... diseases, today announced that Dr. Stacie Canan has joined the company as its ... served as Executive Director of Global Health at Bristol Myers Squibb (formerly Celgene), ...
Breaking Biology News(10 mins):
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a ... has closed on the purchase of greenfield for a new, expanded manufacturing facility. ... over 21 acres in the initial acquisition, with an option to purchase an ...
(Date:7/31/2020)... ... , ... R3 Stem Cell International is now offering patients the opportunity to ... total, patients may choose which extremities they would like treated. , Several studies have ... 2016). At R3 International, umbilical cord tissue is obtained from a lab with a ...
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet Products has introduced new ... for use with CRM, neurostimulation, vascular, and related devices. , Anomet Medical ... requirements, performance, and cost criteria; especially where solid wire is limited. Typical configurations ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... of the top radiation centers in 16 countries, has reached its 20th anniversary ... is now in routine use at top universities including University of Pennsylvania, University ...
Breaking Biology Technology:
Cached News: